GlassScriptPhysician profile
Paul D Feldman
NPI 1588656367
$44,491.96
in general payments reported to CMS, 2019-2025
21 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,268 · 2020: $2,196 · 2021: $5,297 · 2022: $5,825 · 2023: $3,920 · 2024: $6,592 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $8,567 · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,038.90 |
| Food and Beverage | $8,567.15 |
| Education | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,467.05 | 2021-2025 | Venaseal, Closurefast |
| Allergan, INC. | $7,145.32 | 2019-2023 | |
| Merz North America, INC. | $6,810.01 | 2021-2023 | Xeomin |
| Abbvie INC. | $4,970.03 | 2023-2025 | |
| Galderma Laboratories, L.P. | $2,235.54 | 2019-2025 | Dysport |
| Revance Therapeutics, INC. | $2,029.19 | 2024-2025 | Daxxify |
| Boston Scientific Corporation | $1,004.60 | 2020-2025 | Varithena Administration Pack |
| Medtronic Vascular, INC. | $790.31 | 2019-2020 | |
| Angiodynamics, INC. | $327.42 | 2019-2023 | Venacure 1470 Pro |
| Mentor Worldwide LLC | $171.01 | 2019-2021 | |
| Philips North America LLC | $129.53 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $74.32 | 2020 | |
| Medtronic USA, INC. | $70.78 | 2019 | |
| Bard Peripheral Vascular, INC. | $65.70 | 2021-2023 | Venclose Maven Catheter |
| Bsn Medical INC | $35.69 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $33.68 | 2023-2025 | Eliquis |
| Convatec INC. | $33.65 | 2023 | |
| Tactile Systems Technology INC | $29.25 | 2019-2020 | |
| Solventum Corporation | $24.48 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Medline Industries LP | $22.94 | 2024 | |
| Organogenesis INC. | $21.46 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.